ALMKT:EPA
Mauna Kea Technologies SA
0,089 €
arrow_downward
−0,33%(−0,00030) 1D
20. stu, 12:02:18 GMT+1 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za ALMKT...
Otvori
0,09 €
Najviša
0,09 €
Najniža
0,09 €
Trž. kap.
17,17 mil.
Prosj. kol.
406,96 tis.
Količina
163,07 tis.
P/E omjer
0,76
52-tjed. najviša
0,23 €
52-tjed. najniža
0,07 €
EPS
0,12 €
Dionice u optjecaju
195,26 mil.
Broj djelatnika
56
Otvori
0,09 €
Najviša
0,09 €
Najniža
0,09 €
Trž. kap.
17,17 mil.
Prosj. kol.
406,96 tis.
Količina
163,07 tis.
P/E omjer
0,76
52-tjed. najviša
0,23 €
52-tjed. najniža
0,07 €
EPS
0,12 €
Dionice u optjecaju
195,26 mil.
Broj djelatnika
56
Vijesti
Iz web-izvora i od partnera za vijesti
Adam Feldman | Substack
·
prije 17 sati
Inside the Federal Litigation of Five S&P 500 Giants
Benzinga
·
prije 1 sat
Stock Market Today: Dow Jones, S&P 500 Futures Fall as Trump Weighs Iran Decision— INTU, ROST, KEYS in Focus
The Motley Fool
·
prije 1 sat
Bitcoin Is 35% Below Its 52-Week High While the S&P 500 Is Up. Here’s What That Says About the Digital Gold Thesis.
Poslovni dnevnik
·
prije 3 sata
Ni najveći IPO u povijesti nije zaustavio pad Wall Streeta: Dow Jones potonuo više od 1100 bodova
Profil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Mauna Kea Technologies SA – informacije
Glavni izvršni direktorSacha Loiseau
Zaposlenici56
Osnovano2000
Sjedište-
SektorHealth Care
Djelatnost-
Web-lokacijamaunakeatech.com